Several studies indicate that there is an as yet undefined species-specific pneumococcal antigen(s) that can elicit antibody protective against multiple Streptococcus pneumoniae serotypes (1, 9, 15, 16) . One candidate for such an antigen is the phosphocholine (PC) determinant of pneumococcal C carbohydrate, which is believed to be a cell wall component of pneumococcal strains of all capsular types (7) . Previously, we have demonstrated that antibody specific for PC can be protective against infections with type 3 S. pneumoniae in mice hemizygous for the Xlinked immunodeficiency (xid) allele (4) . These mice have very low antibody responses to most carbohydrate antigens, including the PC determinant of C carbohydrate, and are extremely susceptible to infection with type 3 pneumococci. However, they can be protected with naturally occurring anti-PC antibody found in the normal serum of other mouse strains (4) .
The protective effects of anti-PC antibody have been unanticipated (12) since it has been expected that much or all of the C carbohydrate antigenic determinants are masked by the thick type 3 capsule (17) . To determine whether anti-PC antibody would protect mice from other S. pneumoniae strains, we examined the binding of radiolabeled anti-PC antibody to strains of several pneumococcal types, including the type 3 strain WU2 used in earlier experiments. We also studied the relative ability of these pneumococci to infect xid and normal mice and the ability of hybridoma anti-PC antibody to (14) obtained from K. Schroer (National Cancer Institute, Bethesda, Md.) and anti-Salmonella antibody (IgM, ST-1) (3a) were used as diluted ascites fluid and quantitated by isotype-specific radioimmunoassays (5) .
Assay for anti-PC-binding capacity. Radioactive antibody solution contained 20,000 cpm of 125I-labeled (11) IgM antibody to PC (22.1A4) and 20,000 cpm of 57CoC13 (as a volume marker) per 0.2 ml in 1% bovine serum albumin and 0.1 mM diethylenetriamine pentaacetic acid (DTPA) in phosphate-buffered saline (0.15 M NaCl, 0.0092 M K2HPO4, 0.0022 M KH2PO4, pH 7.2). This solution was filtered through a 0.45-,um membrane ifiter (Millipore Corp., Bedford, Mass.) immediately before use to remove aggregates. 57CoC13 and DTPA were mixed in phosphate-buffered saline before the addition of other components. Serial 10-fold dilutions of log-phase cultures of pneumococci were made in 1% bovine serum albumin in phosphatebuffered saline. A 0.1-ml amount of each dilution was added to 0.2 ml of the radioactive antibody solution in 1.5-ml Eppendorf tubes (in triplicate). These mixtures were incubated for 30 min at 37°C and then centrifuged for 10 min at 12,000 x g. Approximately 90%o of the supernatant was removed and the remainder plus the pellet were counted in a two-channel fy-counter. 
RESULTS
Susceptibility to pneumococcal infection. To determine whether the immunodeficiency of the C x D male mice would affect susceptibility to pneumococcal infection with strains other than WU2, LD50 determinations were made for both normal mice (CBA/J, C x D females, D x C males, Swiss females) and the immunodeficient (xid) C x D males by using four additional S. pneumoniae strains given intravenously. Table 1 shows the mortality data for type 3 strain A66 in C x D male and C x D female mice. These data indicate that the LD50 of A66 in C x D males is less than 10 CFU and is about 104 CFU in C x D females. Figure 1 summarizes the LD50 data obtained with five different S. pneumoniae. The values for LD50 were 200-to 2,000-fold lower in pneumoniae strains in antibody to the type 3 capsule were alive 3 days I normal (C x D female, after infection (Fig. 3) . All six unprotected mice at least 5 carbohydrates (7) and their F antigens (6) . To determine whether this PC is accessible to anti-PC antibody, we determined the ability of varying amounts of bacteria of several S. pneumoniae strains to bind a 125I-labeled IgM hybridoma antibody (22.1A4) to PC. As a positive control, R36A, an unencapsulated type 2 bacterium was used. Nonspecific binding to bacteria was determined with L. monocytogenes. As shown in Fig. 2 , all pneumococcal strains bound a significant amount of antibody when compared with L. monocytogenes. At a concentration of 3 x 108 bacteria, the encapsulated pneumococci bound an average of 15% of the available anti-PC antibody, whereas L. monocytogenes bound 0%. An equivalent number of unencapsulated pneumococci bound 55% of the available antibody. About 300 times as many encapsulated pneumococci were required to show binding equivalent to that of the unencapsulated strain.
DISCUSSION
This study suggests that anti-PC antibody may be protective against many strains of S. pneumoniae. This conclusion is based on three types of data. In one set of experiments we showed that type 3 (strain A66), type 6A, and type 19F pneumococci were more virulent in xid mice than in normal mice. This finding was consistent with the protective role of natural anti-PC antibody demonstrated in an earlier study, where it has been shown that the extreme susceptibility of xid mice to type 3 strain WU2 can be eliminated with passive anti-PC antibody from the normal serum of non-xid mice (4) .
In other experiments we showed that hybridoma antibody to PC was able to protect immunologically normal mice from lethal doses of type 1 
